1. Home
  2. RCON vs CRBU Comparison

RCON vs CRBU Comparison

Compare RCON & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCON
  • CRBU
  • Stock Information
  • Founded
  • RCON 2007
  • CRBU 2011
  • Country
  • RCON China
  • CRBU United States
  • Employees
  • RCON N/A
  • CRBU N/A
  • Industry
  • RCON Oilfield Services/Equipment
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • RCON Energy
  • CRBU Health Care
  • Exchange
  • RCON Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • RCON 82.1M
  • CRBU 93.0M
  • IPO Year
  • RCON 2009
  • CRBU 2021
  • Fundamental
  • Price
  • RCON $2.53
  • CRBU $2.03
  • Analyst Decision
  • RCON
  • CRBU Strong Buy
  • Analyst Count
  • RCON 0
  • CRBU 4
  • Target Price
  • RCON N/A
  • CRBU $8.50
  • AVG Volume (30 Days)
  • RCON 19.9K
  • CRBU 2.1M
  • Earning Date
  • RCON 07-29-2025
  • CRBU 08-05-2025
  • Dividend Yield
  • RCON N/A
  • CRBU N/A
  • EPS Growth
  • RCON N/A
  • CRBU N/A
  • EPS
  • RCON N/A
  • CRBU N/A
  • Revenue
  • RCON $8,996,572.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • RCON N/A
  • CRBU $9.52
  • Revenue Next Year
  • RCON $12.17
  • CRBU N/A
  • P/E Ratio
  • RCON N/A
  • CRBU N/A
  • Revenue Growth
  • RCON N/A
  • CRBU N/A
  • 52 Week Low
  • RCON $1.39
  • CRBU $0.66
  • 52 Week High
  • RCON $3.70
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RCON 53.18
  • CRBU 71.36
  • Support Level
  • RCON $2.21
  • CRBU $1.61
  • Resistance Level
  • RCON $2.68
  • CRBU $1.79
  • Average True Range (ATR)
  • RCON 0.17
  • CRBU 0.13
  • MACD
  • RCON -0.02
  • CRBU 0.03
  • Stochastic Oscillator
  • RCON 61.76
  • CRBU 92.25

About RCON Recon Technology Ltd.

Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: